SK Bioscience Co. on Thursday reported its 2023 net profit of 22.3 billion won (US$16.8 million), down 81.8 percent from a year earlier. The company said in a regulatory filing that it posted an operating loss of 12 billion won for the year, compared with a profit of 115 billion won from the previous year. Annual revenue fell 19.1 percent to 369.5 billion won. (END) Source: Yonhap News Agency
Myanmar Clears Path for Junta Leader to Become President
March 30, 2026